Patents by Inventor Simon Lofts

Simon Lofts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140197253
    Abstract: A system and method for separating polymer components of a multi-component article, such as a shoe, is presented. The described system and method exploits the differences in embrittlement and glass transition temperature of different polymer components of the multi-component article by cryogenically freezing the prepared article and impacting the article such that one polymer component is pulverized without substantially fracturing the remaining portion of the article. The system and method further includes a re-looping capability to maximize separation and recovery of polymer components.
    Type: Application
    Filed: January 17, 2013
    Publication date: July 17, 2014
    Applicant: Nike, Inc.
    Inventors: Simon Lofts, Graham Stevens, Nat Egosi
  • Patent number: 7317040
    Abstract: A compound of formula (I): namely (2S)-2-amino-4-{[2-(ethanimidoylamino)ethyl]thio}butanoic acid, compound with phosphoric acid, or a solvate or physiologically functional derivative thereof, is useful as a relatively non-hygroscopic selective inhibitor of inducible nitric oxide synthase.
    Type: Grant
    Filed: December 17, 2001
    Date of Patent: January 8, 2008
    Assignee: SmithKline Beecham Corporation
    Inventors: David Box, David Colclough, Iain Gillies, Michael Simon Loft, Rebecca Moore
  • Publication number: 20040087654
    Abstract: A compound of formula (I): namely (2S)-2-amino-4-{[2-(etha-nimidoylamino)ethyl]thio}butanoic acid, compound with prosphoric acid, or a solvate or physiologically functional derivative thereof, is useful as a relatively non-hygroscopic selective inhibitor of inducible nitric oxice synthase.
    Type: Application
    Filed: November 11, 2003
    Publication date: May 6, 2004
    Inventors: David Box, David Colclough, Iain Gillies, Michael Simon Loft, Rebecca Moore
  • Patent number: 6599905
    Abstract: Compounds of formula (I) where R1 is phenyl substituted by one or more halogen atoms, naphthyl and naphthyl substituted by one or more halogen atoms; R2 is —NH2 and —NHC(═O)Ra; R3 is —NRbRc, —NHC(═O)Ra or hydrogen; R4 is hydrogen, —C1-4 alkyl, —CN, —CH2OH, —CH2ORd, —CH2S(O)xRd and —C1-4 alkyl substituted by one or more halogen atoms in which Ra represents C1-4 alkyl or C3-7cycloalkyl, and Rb and Rc, which may be the same or different, are hydrogen or C1-4 alkyl, or together with the nitrogen atom to which they are attached, form a 6-membered nitrogen containing heterocycle, which heterocycle can be further substituted with one or more C1-4 alkyl; Rd is C1-4 alkyl or C1-4 alkyl substituted by one or more halogen atoms; x is an integer zero, one or two; and salts, solvates and prodrugs thereof, provided that R1 does not represent: when R2 is —NH2, and both R3 and R4 are hydrogen.
    Type: Grant
    Filed: May 16, 2001
    Date of Patent: July 29, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Brian Cox, Dean David Edney, Michael Simon Loft, Malcolm Stuart Nobbs, Gita Punjabhai Shah
  • Publication number: 20020169172
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: May 16, 2001
    Publication date: November 14, 2002
    Applicant: GLAXO WELLCOME INC.
    Inventors: Brian Cox, Dean David Edney, Michael Simon Loft, Malcolm Stuart Nobbs, Gita Punjabhai Shah
  • Patent number: 6255307
    Abstract: A compound of formula (I) wherein R1 is selected from the group consisting of phenyl substituted by one or more halogen atoms, naphthyl and naphthyl substituted by one or more halogen atoms; R2 is selected from the group consisting of —NH2 and —NHC(═O)Ra; R3 is selected from the group consisting of —NRbRc, —NHC(═O)Ra and hydrogen, R4 is selected from the group consisting of hydrogen, -C1-4 alkyl, -C1-4 alkyl substituted by one or more halogen atoms, —CN, —CH2OH, —CH2ORd and —CH2S(O)xRd; wherein Ra represents C1-4 alkyl or C3-7cycloalkyl, and Rb and Rc, which may be the same or different, are selected from hydrogen and C1-4 alkyl, or together with the nitrogen atom to which they are attached, form a 6-membered nitrogen containing heterocycle, which heterocycle can be further susbtituted with one or more C1-4 alkyl; Rd is selected from C1-4 alkyl or C1-4 alkyl substituted by one or more halogen atoms; x is an integer zero, one or two; and pharmaceuticall
    Type: Grant
    Filed: August 25, 1999
    Date of Patent: July 3, 2001
    Assignee: Glaxo Wellcome, Inc.
    Inventors: Brian Cox, Dean David Edney, Michael Simon Loft, Malcolm Stuart Nobbs, Gita Punjabhai Shah